Treatment of menopausal symptoms by an extract from the roots of rhapontic rhubarb: The role of estrogen receptors

Chinese Medicine

Volumn 5, Issue , 2010, Pages

  Vollmer, Günter ^a   Papke, Anja ^a   Zierau, Oliver ^a  

^a DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ESTRADIOL; ESTROGEN; ESTROGEN RECEPTOR BETA; PLANT EXTRACT; RHEUM RHAPONTICUM EXTRACT; UNCLASSIFIED DRUG;

AMENORRHEA; BINDING AFFINITY; CHINESE MEDICINE; CLIMACTERIUM; CLINICAL TRIAL; DRUG EFFICACY; DRUG RECEPTOR BINDING; DRUG SAFETY; DRUG SPECIFICITY; ENDOMETRIUM HYPERPLASIA; ESTROGEN ACTIVITY; HAMILTON ANXIETY SCALE; HORMONE SUBSTITUTION; HOT FLUSH; HUMAN; MENOPAUSAL SYNDROME; NONHUMAN; OVARY INSUFFICIENCY; PLANT ROOT; QUALITY OF LIFE; REVIEW; RHEUM RHAPONTICUM; RHUBARB;

EID: 77649285199     PISSN: None     EISSN: 17498546     Source Type: Journal    
DOI: 10.1186/1749-8546-5-7     Document Type: Review

References (30)

1. Rupprich N, Hildebrand H, Kindl H. Substrate specificity in vivo and in vitro in the formation of stilbenes. Biosynthesis of rhaponticin. Arch Biochem Biophys 1980, 200(1):72-78. 10.1016/0003-9861(80)90332-X, 7362262.
2. IARC IARC monographs on the evaluation of the carcinogenic risk of chemicals to humans. Sex hormones (II). IARC Monogr Eval Carcinog Risk Chem Hum 1979, 21:11-561. IARC.
3. Herbst AL. Diethylstilbestrol and adenocarcinoma of the vagina. Am J Obstet Gynecol 1999, 181(6):1576-1578. discussion 1579, 10.1016/S0002-9378(99)70412-6, 10601947.
4. Kaszkin-Bettag M, Richardson A, Rettenberger R, Heger PW. Long-term toxicity studies in dogs support the safety of the special extract ERr 731 from the roots of Rheum rhaponticum. Food Chem Toxicol 2008, 46(5):1608-1618.
5. Hasper I, Ventskovskiy BM, Rettenberger R, Heger PW, Riley DS, Kaszkin-Bettag M. Long-term efficacy and safety of the special extract ERr 731 of Rheum rhaponticum in perimenopausal women with menopausal symptoms. Menopause 2009, 16(1):117-131. 10.1097/gme.0b013e3181806446, 18978638.
6. Johannes CB, Crawford SL. Menstrual bleeding, hormones, and the menopausal transition. Semin Reprod Endocrinol 1999, 17(4):299-309.
7. Beral V. Breast cancer and hormone-replacement therapy in the Million Women Study. Lancet 2003, 362(9382):419-427. 10.1016/S0140-6736(03)14065-2, 12927427.
8. Beral V, Bull D, Reeves G. Endometrial cancer and hormone-replacement therapy in the Million Women Study. Lancet 2005, 365(9470):1543-1551. 10.1016/S0140-6736(05)66455-0, 15866308.
9. Heger M, Ventskovskiy BM, Borzenko I, Kneis KC, Rettenberger R, Kaszkin-Bettag M, Heger PW. Efficacy and safety of a special extract of Rheum rhaponticum (ERr 731) in perimenopausal women with climacteric complaints: a 12-week randomized, double-blind, placebo-controlled trial. Menopause 2006, 13(5):744-759. 10.1097/01.gme.0000240632.08182.e4, 16894335.
10. Kaszkin-Bettag M, Ventskovskiy BM, Kravchenko A, Rettenberger R, Richardson A, Heger PW, Heger M. The special extract ERr 731 of the roots of Rheum rhaponticum decreases anxiety and improves health state and general well-being in perimenopausal women. Menopause 2007, 14(2):270-283. 10.1097/01.gme.0000251932.48426.35, 17213754.
11. Kuiper GG, Lemmen JG, Carlsson B, Corton JC, Safe SH, Saag PT, Burg B, Gustafsson JA. Interaction of estrogenic chemicals and phytoestrogens with estrogen receptor beta. Endocrinology 1998, 139(10):4252-4263. 10.1210/en.139.10.4252, 9751507.
12. Kanno J, Onyon L, Peddada S, Ashby J, Jacob E, Owens W. The OECD program to validate the rat uterotrophic bioassay. Phase 2: coded single-dose studies. Environ Health Perspect 2003, 111(12):1550-1558. 1241660, 12948897.
13. Kanno J, Onyon L, Peddada S, Ashby J, Jacob E, Owens W. The OECD program to validate the rat uterotrophic bioassay. Phase 2: dose-response studies. Environ Health Perspect 2003, 111(12):1530-1549. 1241659, 12948896.
14. Diel P, Schmidt S, Vollmer G. In vivo test systems for the quantitative and qualitative analysis of the biological activity of phytoestrogens. J Chromatogr B Analyt Technol Biomed Life Sci 2002, 777(1-2):191-202. 10.1016/S1570-0232(02)00494-4, 12270212.
15. Mueller SO, Simon S, Chae K, Metzler M, Korach KS. Phytoestrogens and their human metabolites show distinct agonistic and antagonistic properties on estrogen receptor alpha (ERalpha) and ERbeta in human cells. Toxicol Sci 2004, 80(1):14-25. 10.1093/toxsci/kfh147, 15084758.
16. Wober J, Moller F, Richter T, Unger C, Weigt C, Jandausch A, Zierau O, Rettenberger R, Kaszkin-Bettag M, Vollmer G. Activation of estrogen receptor-beta by a special extract of Rheum rhaponticum (ERr 731((R))), its aglycones and structurally related compounds. J Steroid Biochem Mol Biol 2007, 107(3-5):191-201. 10.1016/j.jsbmb.2007.04.002, 17692514.
17. Moller F, Zierau O, Jandausch A, Rettenberger R, Kaszkin-Bettag M, Vollmer G. Subtype-specific activation of estrogen receptors by a special extract of Rheum rhaponticum (ERr 731), its aglycones and structurally related compounds in U2OS human osteosarcoma cells. Phytomedicine 2007, 14(11):716-726. 10.1016/j.phymed.2007.09.001, 17935960.
18. Pike AC, Brzozowski AM, Hubbard RE. A structural biologist's view of the oestrogen receptor. J Steroid Biochem Mol Biol 2000, 74(5):261-268. 10.1016/S0960-0760(00)00102-3, 11162934.
19. Wang Y, Chirgadze NY, Briggs SL, Khan S, Jensen EV, Burris TP. A second binding site for hydroxytamoxifen within the coactivator-binding groove of estrogen receptor beta. Proc Natl Acad Sci USA 2006, 103(26):9908-9911. 10.1073/pnas.0510596103, 1502552, 16782818.
20. Kojetin DJ, Burris TP, Jensen EV, Khan SA. Implications of the binding of tamoxifen to the coactivator recognition site of the estrogen receptor. Endocr Relat Cancer 2008, 15(4):851-870. 10.1677/ERC-07-0281, 18755852.
21. Damdimopoulos AE, Spyrou G, Gustafsson JA. Ligands differentially modify the nuclear mobility of estrogen receptors alpha and beta. Endocrinology 2008, 149(1):339-345. 10.1210/en.2007-0198, 17884941.
22. Papke A, Kretzschmar G, Zierau O, Kaszkin-Bettag M, Vollmer G. Effects of the special extract ERr 731 from Rheum rhaponticum on estrogen-regulated targets in the uterotrophy model of ovariectomized rats. J Steroid Biochem Mol Biol 2009, 117(4-5):176-184. 10.1016/j.jsbmb.2009.09.011, 19808094.
23. O'Brien JE, Peterson TJ, Tong MH, Lee EJ, Pfaff LE, Hewitt SC, Korach KS, Weiss J, Jameson JL. Estrogen-induced proliferation of uterine epithelial cells is independent of estrogen receptor alpha binding to classical estrogen response elements. J Biol Chem 2006, 281(36):26683-26692. 10.1074/jbc.M601522200, 16847062.
24. Crabtree JS, Peano BJ, Zhang X, Komm BS, Winneker RC, Harris HA. Activity of three selective estrogen receptor modulators on hormone-dependent responses in the mouse uterus and mammary gland. Mol Cell Endocrinol 2008, 287(1-2):40-46. 10.1016/j.mce.2008.01.027, 18367319.
25. Blizzard TA. Selective estrogen receptor modulator medicinal chemistry at Merck. A review. Curr Top Med Chem 2008, 8(9):792-812. 10.2174/156802608784535066, 18537689.
26. Li JX, Xue B, Chai Q, Liu ZX, Zhao AP, Chen LB. Antihypertensive effect of total flavonoid fraction of Astragalus complanatus in hypertensive rats. Chin J Physiol 2005, 48(2):101-106.
27. Liu CY, Gu ZL, Zhou WX, Guo CY. Effect of Astragalus complanatus flavonoid on anti-liver fibrosis in rats. World J Gastroenterol 2005, 11(37):5782-5786.
28. Xue B, Li J, Chai Q, Liu Z, Chen L. Effect of total flavonoid fraction of Astragalus complanatus R.Brown on angiotensin II-induced portal-vein contraction in hypertensive rats. Phytomedicine 2008, 15(9):759-762. 10.1016/j.phymed.2007.11.030, 18406589.
29. Zhang CZ, Wang SX, Zhang Y, Chen JP, Liang XM. In vitro estrogenic activities of Chinese medicinal plants traditionally used for the management of menopausal symptoms. J Ethnopharmacol 2005, 98(3):295-300. 10.1016/j.jep.2005.01.033, 15814262.
30. Imwalle DB, Gustafsson JA, Rissman EF. Lack of functional estrogen receptor beta influences anxiety behavior and serotonin content in female mice. Physiol Behav 2005, 84(1):157-163. 10.1016/j.physbeh.2004.11.002, 15642619.